Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 9NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasm Metastasis 1Central Nervous System Carcinoma 1

Interventions

Radiotherapy 18Temozolomide 11Vincristine 10Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8Carboplatin 8Cyclophosphamide 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Radiotherapy, Conformal 5Radiosurgery 5Peripheral Blood Stem Cell Transplantation 5Lomustine 5etoposide phosphate 4Thiotepa 3Immunohistochemistry 3Chemotherapy, Adjuvant 3Bevacizumab 3sargramostim 2Topotecan 2Psychiatric Rehabilitation 2Proton Therapy 2Procarbazine 2Microarray Analysis 2Mesna 2Mental Status and Dementia Tests 2Memantine 2In Situ Hybridization, Fluorescence 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Brain Neoplasms × Memantine × Clear all
NCT03550391 2026-05-12

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Canadian Cancer Trials Group

Phase 3 Recruiting
206 enrolled
CNS

Brain Neoplasms

NCT00566852 2017-08-21

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Radiation Therapy Oncology Group

Phase 3 Completed
554 enrolled 12 charts
CNS

Brain Neoplasms, Neoplasm Metastasis, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡